These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9156031)

  • 1. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
    Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Tormey W; Smith D; Thompson CJ; McKenna MJ; Agha A
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of optimal hydrocortisone replacement therapy.
    Howlett TA
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):263-8. PubMed ID: 9156032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study.
    Cooper MS; Syddall HE; Fall CH; Wood PJ; Stewart PM; Cooper C; Dennison EM
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):692-7. PubMed ID: 15943831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy.
    Dineen R; Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Keevil BG; Tormey W; Smith D; Thompson CJ; McKenna MJ; Arlt W; Stewart PM; Agha A; Sherlock M
    BMC Endocr Disord; 2020 Oct; 20(1):154. PubMed ID: 33036588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.
    Beshyah SA; Kyd P; Thomas E; Fairney A; Johnston DG
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):249-54. PubMed ID: 7758229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial.
    Greenspan SL; Resnick NM; Parker RA
    J Clin Endocrinol Metab; 2005 May; 90(5):2762-7. PubMed ID: 15713726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
    Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
    DeVile CJ; Stanhope R
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K; Thorsen TE; Husebye ES
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L; Lentjes E; Hermus A; Zelissen P
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease.
    Zelissen PM; Croughs RJ; van Rijk PP; Raymakers JA
    Ann Intern Med; 1994 Feb; 120(3):207-10. PubMed ID: 8273983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):739-50. PubMed ID: 11422108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
    Girgis R; Winter JS
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.